| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Laboratory of Molecular Endocrinology, CHUL Research Center and Department of Anatomy and Physiology, Laval University, Sainte-Foy, Québec, Canada G1V 4G2
Address all correspondence and requests for reprints to: Dr. Serge Rivest, Laboratory of Molecular Endocrinology, CHUL Research Center, 2705 Laurier boulevard, Sainte-Foy, Québec, Canada G1V 4G2. E-mail: serge.rivest{at}crchul.ulaval.ca
Interleukin-6 (IL-6) is a proinflammatory cytokine that plays multiple roles in the central nervous system during infections and injuries. Although this molecule is capable of stimulating the release of ACTH and glucocorticoids, it has been demonstrated that a single injection of IL-6 fails to activate the paraventricular nucleus (PVN) neurons that control the hypothalamic-pituitary-adrenal axis. The observation that IL-6 receptor (IL-6R) is up-regulated in the brain during endotoxemia led us to hypothesize that prior induction of IL-6R synthesis could amplify the effect of circulating IL-6 on the neuroendocrine response. Rats received a first iv injection of either bacterial lipopolysaccharide (LPS; 5 µg) or vehicle solution. After a 6-h waiting period, they received a second iv injection of either recombinant rat IL-6 or vehicle solution and were killed 1 h thereafter. Using in situ hybridization, we observed that IL-6R was barely expressed in the PVN under basal conditions, but was rapidly produced in response to LPS. IL-6 itself was also able to induce the synthesis of its own receptor along cerebral blood vessels, and this effect extended to several parenchymal structures, including the PVN, when the cytokine was administrated after LPS. In agreement with our hypothesis, we found that IL-6 injected in LPS-pretreated rats stimulated PVN neurons, as revealed by the expression of CRF primary transcript and c-fos messenger RNA, an immediate early gene used as a marker of cellular activation. A significant increase in plasma corticosterone levels was also found in animals that received iv IL-6 injection after being pretreated 6 h before with the very low dose of LPS. The fact that IL-6 alone or injected after LPS treatment was unable to induce cyclooxygenase-2 synthesis is an argument in favor of a PG-independent mechanism. The relative contribution of IL-6 in stimulating CRF expression in the PVN and neural activity throughout the brain during endotoxemia was also investigated in IL-6-deficient mice after an ip injection of LPS. The endotoxin induced similar c-fos and CRF expression patterns in knockout and wild-type mice, but the expression levels were generally higher and/or lasted longer in wild-type animals. Taken together, physiological changes that may include the induction of IL-6R synthesis seem to be necessary for IL-6 to activate PVN neurons. Moreover, although IL-6 does not appear essential during the early phases of endotoxemia, this cytokine is required during the later phases to prolong the activation of neural cells throughout the brain and to maintain CRF expression in the PVN neurons that control the hypothalamic-pituitary-adrenal axis.
This article has been cited by other articles:
 |
|
 |
|
  K. Kageyama, K. Hanada, Y. Iwasaki, S. Sakihara, T. Nigawara, J. Kasckow, and T. Suda Pituitary adenylate cyclase-activating polypeptide stimulates corticotropin-releasing factor, vasopressin and interleukin-6 gene transcription in hypothalamic 4B cells J. Endocrinol., November 1, 2007; 195(2): 199 - 211. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Dominguez-Punaro, M. Segura, M.-M. Plante, S. Lacouture, S. Rivest, and M. Gottschalk Streptococcus suis Serotype 2, an Important Swine and Human Pathogen, Induces Strong Systemic and Cerebral Inflammatory Responses in a Mouse Model of Infection J. Immunol., August 1, 2007; 179(3): 1842 - 1854. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Helwig, T. I. Musch, R. A. Craig, and M. J. Kenney Increased interleukin-6 receptor expression in the paraventricular nucleus of rats with heart failure Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2007; 292(3): R1165 - R1173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Rummel, C. Sachot, S. Poole, and G. N. Luheshi Circulating interleukin-6 induces fever through a STAT3-linked activation of COX-2 in the brain Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1316 - R1326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. L. Sparkman, J. B. Buchanan, J. R. R. Heyen, J. Chen, J. L. Beverly, and R. W. Johnson Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J. Neurosci., October 18, 2006; 26(42): 10709 - 10716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Wernstedt, A. Edgley, A. Berndtsson, J. Faldt, G. Bergstrom, V. Wallenius, and J.-O. Jansson Reduced stress- and cold-induced increase in energy expenditure in interleukin-6-deficient mice Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2006; 291(3): R551 - R557. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Komori, S. Miyahara, M. Yamamoto, T. Matsumoto, K. Zhang, M. Nakagawa, S. Nomura, E. Motomura, T. Shiroyama, and Y. Okazaki Effects of Odorants on the Hypothalamic-Pituitary-Adrenal Axis and Interleukin-6 (IL-6) and IL-6 Receptor mRNA Expression in Rat Hypothalamus after Restraint Stress Chem Senses, November 1, 2003; 28(9): 767 - 771. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Beishuizen and L. G. Thijs Review: Endotoxin and the hypothalamo-pituitary-adrenal (HPA) axis Innate Immunity, February 1, 2003; 9(1): 3 - 24. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Rivest Editorial: Does Circulating Leptin Have the Ability to Cross the Blood-Brain Barrier and Target Neurons Directly? Endocrinology, September 1, 2002; 143(9): 3211 - 3213. [Full Text] [PDF]
|
|
|
|
|
|
V. Chesnokova and S. Melmed Minireview: Neuro-Immuno-Endocrine Modulation of the Hypothalamic-Pituitary-Adrenal (HPA) Axis by gp130 Signaling Molecules Endocrinology, May 1, 2002; 143(5): 1571 - 1574. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Johnson, S. K. Vogt, M. W. Burney, and L. J. Muglia COX-2 inhibition attenuates anorexia during systemic inflammation without impairing cytokine production Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E650 - E656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Vallieres, I. L. Campbell, F. H. Gage, and P. E. Sawchenko Reduced Hippocampal Neurogenesis in Adult Transgenic Mice with Chronic Astrocytic Production of Interleukin-6 J. Neurosci., January 15, 2002; 22(2): 486 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Marks, N. Ling, and R. D. Cone Role of the Central Melanocortin System in Cachexia Cancer Res., February 1, 2001; 61(4): 1432 - 1438. [Abstract] [Full Text]
|
|
|
|
|
|
E. LeBel, L. Vallieres, and S. Rivest Selective Involvement of Interleukin-6 in the Transcriptional Activation of the Suppressor of Cytokine Signaling-3 in the Brain during Systemic Immune Challenges Endocrinology, October 1, 2000; 141(10): 3749 - 3763. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Rivest, S. Lacroix, L. Vallières, S. Nadeau, J. Zhang, and N. Laflamme How the Blood Talks to the Brain Parenchyma and the Paraventricular Nucleus of the Hypothalamus During Systemic Inflammatory and Infectious Stimuli Experimental Biology and Medicine, January 1, 2000; 223(1): 22 - 38. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
